The Erk1/2-EGR1 signaling pathway is involved in lipopolysaccharide-induced transforming growth factor-beta 1 expression in mouse macrophages
Microbial Pathogenesis · 2025-06 · 203 · 107453
DOI: 10.1016/j.micpath.2025.107453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2025-06. Verfasst von Weimin Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Province Engineering Research Center of Precision Animal Breeding, Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cu…. Hauptthemen laut MEDLINE: Lipopolysaccharides, Early Growth Response Protein 1, Macrophages, Transforming Growth Factor beta1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Jiangsu Province Natural Science Foundation, Jiangsu Provincial Agricultural Science and Technology Innovation Fund, National Natural Science Foundation of China.
Abstract (Originalsprache)
Numerous studies have demonstrated that lipopolysaccharide (LPS) stimulates TGF-β1 expression. Although studies have implicated the NF-κB/METTL3/METTL14 transactivation/m6A-dependent and AMPK-dependent signaling pathways are engaged in this process in a variety of cell types, the underlying regulatory mechanism in murine macrophages is still not fully understood. To address this issue, in vitro studies were performed using the murine macrophage cell line, RAW264.7. The results showed that LPS challenge resulted in a significant increase in TGF-β1 expression at both mRNA and protein levels. Subsequent studies revealed that the MAPK (including p38, Erk1/2, and JNK) and NF-κB signaling pathways were activated in response to LPS stimulation, but only blocking the Erk1/2 singling pathway completely abolished LPS-induced TGF-β1 expression. Further studies revealed that the levels of a downstream regulator of the Erk1/2 pathway, EGR1, were significantly increased after LPS treatment, and its knockdown significantly reduced LPS-induced Tgf-β1 expression levels. Finally, dual luciferase reporter and ChIP-PCR assays confirmed that EGR1 is a key transcription factor in the regulation of Tgf-β1 expression by binding to its promoter region in response to LPS stimulation. In conclusion, we elucidated the molecular events by which LPS regulates TGF-β1 expression in murine macrophages through the Erk1/2-EGR1 signaling pathway. These findings provide a conceptually novel pathway for LPS-induced TGF-β1 expression beyond the known NF-κB/METTL3/METTL14 transactivation/m6A-dependent and AMPK-dependent signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Province Engineering Research Center of Precision Animal Breeding, Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base of Ministry of Science and Technology, Institute of Ani…
Förderung
- Jiangsu Province Natural Science Foundation
- Jiangsu Provincial Agricultural Science and Technology Innovation Fund
- National Natural Science Foundation of China
- National Swine Industry Technology System
Zitieren
APA
Zhao, W., Wang, H., Dai, C., Li, B., Fu, Y., Cheng, J., & Li, H. (2025). The Erk1/2-EGR1 signaling pathway is involved in lipopolysaccharide-induced transforming growth factor-beta 1 expression in mouse macrophages. Microbial Pathogenesis, 203, 107453. https://doi.org/10.1016/j.micpath.2025.107453
Vancouver
Zhao W, Wang H, Dai C, Li B, Fu Y, Cheng J, et al. The Erk1/2-EGR1 signaling pathway is involved in lipopolysaccharide-induced transforming growth factor-beta 1 expression in mouse macrophages. Microbial Pathogenesis. 2025;203:107453. doi:10.1016/j.micpath.2025.107453
BibTeX
@article{Zhao2025,
author = {Zhao, Weimin and Wang, Hong and Dai, Chaohui and Li, Bixia and Fu, Yanfeng and Cheng, Jinhua and Li, Hui},
title = {The Erk1/2-EGR1 signaling pathway is involved in lipopolysaccharide-induced transforming growth factor-beta 1 expression in mouse macrophages},
journal = {Microbial Pathogenesis},
year = {2025},
volume = {203},
pages = {107453},
doi = {10.1016/j.micpath.2025.107453}
}
EUVIMED